nodes	percent_of_prediction	percent_of_DWPC	metapath
Arbutamine—Labetalol—hypertension	0.282	1	CrCtD
Arbutamine—ADRB1—hypertension	0.0841	0.543	CbGaD
Arbutamine—ADRB2—hypertension	0.0707	0.457	CbGaD
Arbutamine—Mirabegron—Labetalol—hypertension	0.0387	0.174	CrCrCtD
Arbutamine—Salmeterol—Labetalol—hypertension	0.0257	0.116	CrCrCtD
Arbutamine—ADRB3—Nadolol—hypertension	0.0245	0.0821	CbGbCtD
Arbutamine—ADRB3—Labetalol—hypertension	0.0245	0.0821	CbGbCtD
Arbutamine—ADRB3—Pindolol—hypertension	0.0208	0.0698	CbGbCtD
Arbutamine—Formoterol—Labetalol—hypertension	0.0197	0.0885	CrCrCtD
Arbutamine—Arformoterol—Labetalol—hypertension	0.0197	0.0885	CrCrCtD
Arbutamine—Dobutamine—Labetalol—hypertension	0.0177	0.0795	CrCrCtD
Arbutamine—Norepinephrine—Methyldopa—hypertension	0.0166	0.0746	CrCrCtD
Arbutamine—Ritodrine—Labetalol—hypertension	0.0137	0.0616	CrCrCtD
Arbutamine—Fenoterol—Labetalol—hypertension	0.0137	0.0616	CrCrCtD
Arbutamine—ADRB2—Esmolol—hypertension	0.0132	0.0443	CbGbCtD
Arbutamine—ADRB1—Esmolol—hypertension	0.013	0.0436	CbGbCtD
Arbutamine—Epinephrine—Methyldopa—hypertension	0.0125	0.0564	CrCrCtD
Arbutamine—ADRB3—Timolol—hypertension	0.012	0.0401	CbGbCtD
Arbutamine—ADRB3—Carvedilol—hypertension	0.0116	0.0388	CbGbCtD
Arbutamine—ADRB3—Propranolol—hypertension	0.0107	0.0357	CbGbCtD
Arbutamine—Isoprenaline—Methyldopa—hypertension	0.0102	0.0459	CrCrCtD
Arbutamine—ADRB2—Nebivolol—hypertension	0.01	0.0336	CbGbCtD
Arbutamine—ADRB2—Nadolol—hypertension	0.01	0.0336	CbGbCtD
Arbutamine—ADRB2—Labetalol—hypertension	0.01	0.0336	CbGbCtD
Arbutamine—ADRB1—Labetalol—hypertension	0.00986	0.033	CbGbCtD
Arbutamine—ADRB1—Nadolol—hypertension	0.00986	0.033	CbGbCtD
Arbutamine—ADRB1—Nebivolol—hypertension	0.00986	0.033	CbGbCtD
Arbutamine—ADRB2—Acebutolol—hypertension	0.00916	0.0307	CbGbCtD
Arbutamine—ADRB1—Acebutolol—hypertension	0.00902	0.0302	CbGbCtD
Arbutamine—Isoprenaline—Pindolol—hypertension	0.00888	0.0399	CrCrCtD
Arbutamine—Labetalol—Quinapril—hypertension	0.00878	0.0395	CrCrCtD
Arbutamine—Labetalol—Benazepril—hypertension	0.00857	0.0385	CrCrCtD
Arbutamine—ADRB2—Metoprolol—hypertension	0.00851	0.0285	CbGbCtD
Arbutamine—ADRB2—Pindolol—hypertension	0.00851	0.0285	CbGbCtD
Arbutamine—ADRB1—Metoprolol—hypertension	0.00838	0.0281	CbGbCtD
Arbutamine—ADRB1—Pindolol—hypertension	0.00838	0.0281	CbGbCtD
Arbutamine—Isoprenaline—Labetalol—hypertension	0.00787	0.0354	CrCrCtD
Arbutamine—ADRB2—Betaxolol—hypertension	0.00759	0.0254	CbGbCtD
Arbutamine—ADRB1—Betaxolol—hypertension	0.00747	0.025	CbGbCtD
Arbutamine—ADRB2—Penbutolol—hypertension	0.00694	0.0233	CbGbCtD
Arbutamine—ADRB1—Penbutolol—hypertension	0.00683	0.0229	CbGbCtD
Arbutamine—ADRB2—Timolol—hypertension	0.00489	0.0164	CbGbCtD
Arbutamine—ADRB1—Timolol—hypertension	0.00482	0.0161	CbGbCtD
Arbutamine—ADRB2—Carvedilol—hypertension	0.00474	0.0159	CbGbCtD
Arbutamine—ADRB1—Carvedilol—hypertension	0.00466	0.0156	CbGbCtD
Arbutamine—ADRB2—Propranolol—hypertension	0.00436	0.0146	CbGbCtD
Arbutamine—ADRB1—Propranolol—hypertension	0.00429	0.0144	CbGbCtD
Arbutamine—ADRB2—Treprostinil—Nadolol—hypertension	0.000614	1	CbGdCrCtD
Arbutamine—Masoprocol—CYP2J2—hypertension	0.000293	0.141	CrCbGaD
Arbutamine—Isoprenaline—PIK3R1—hypertension	0.000172	0.0831	CrCbGaD
Arbutamine—Isoprenaline—ADRBK1—hypertension	0.000125	0.0601	CrCbGaD
Arbutamine—Masoprocol—ALOX5—hypertension	0.000105	0.0506	CrCbGaD
Arbutamine—Epinephrine—ADRBK1—hypertension	0.000105	0.0505	CrCbGaD
Arbutamine—Dobutamine—COMT—hypertension	7.79e-05	0.0376	CrCbGaD
Arbutamine—Salmeterol—CYP3A5—hypertension	6.37e-05	0.0307	CrCbGaD
Arbutamine—Norepinephrine—ADRA2B—hypertension	5.95e-05	0.0287	CrCbGaD
Arbutamine—Fenoterol—ADRB1—hypertension	5.76e-05	0.0278	CrCbGaD
Arbutamine—Masoprocol—CYP19A1—hypertension	5.52e-05	0.0266	CrCbGaD
Arbutamine—Epinephrine—ADRA2B—hypertension	5.4e-05	0.0261	CrCbGaD
Arbutamine—Formoterol—ADRB1—hypertension	5.23e-05	0.0252	CrCbGaD
Arbutamine—Arformoterol—ADRB1—hypertension	5.23e-05	0.0252	CrCbGaD
Arbutamine—Norepinephrine—SLC6A2—hypertension	5.23e-05	0.0252	CrCbGaD
Arbutamine—Salmeterol—ADRB2—hypertension	5.03e-05	0.0243	CrCbGaD
Arbutamine—Dobutamine—ADRB1—hypertension	4.96e-05	0.0239	CrCbGaD
Arbutamine—Fenoterol—ADRB2—hypertension	4.84e-05	0.0234	CrCbGaD
Arbutamine—Ritodrine—ADRB2—hypertension	4.84e-05	0.0234	CrCbGaD
Arbutamine—Arformoterol—ADRB2—hypertension	4.4e-05	0.0212	CrCbGaD
Arbutamine—Formoterol—ADRB2—hypertension	4.4e-05	0.0212	CrCbGaD
Arbutamine—Dobutamine—ADRB2—hypertension	4.17e-05	0.0201	CrCbGaD
Arbutamine—Labetalol—ADRB1—hypertension	3.82e-05	0.0184	CrCbGaD
Arbutamine—Norepinephrine—ADRA1A—hypertension	3.68e-05	0.0178	CrCbGaD
Arbutamine—Epinephrine—ADRA1A—hypertension	3.34e-05	0.0161	CrCbGaD
Arbutamine—Labetalol—ADRB2—hypertension	3.21e-05	0.0155	CrCbGaD
Arbutamine—Isoprenaline—ADRB1—hypertension	2.81e-05	0.0136	CrCbGaD
Arbutamine—Mirabegron—ALB—hypertension	2.63e-05	0.0127	CrCbGaD
Arbutamine—Norepinephrine—ADRA2A—hypertension	2.61e-05	0.0126	CrCbGaD
Arbutamine—Norepinephrine—ADRB1—hypertension	2.6e-05	0.0126	CrCbGaD
Arbutamine—Epinephrine—ADRA2A—hypertension	2.37e-05	0.0114	CrCbGaD
Arbutamine—Isoprenaline—ADRB2—hypertension	2.37e-05	0.0114	CrCbGaD
Arbutamine—Epinephrine—ADRB1—hypertension	2.36e-05	0.0114	CrCbGaD
Arbutamine—Epinephrine—TNF—hypertension	2.24e-05	0.0108	CrCbGaD
Arbutamine—Norepinephrine—ADRB2—hypertension	2.19e-05	0.0106	CrCbGaD
Arbutamine—Isoprenaline—CYP1A1—hypertension	2.03e-05	0.00979	CrCbGaD
Arbutamine—Epinephrine—ADRB2—hypertension	1.99e-05	0.00959	CrCbGaD
Arbutamine—Norepinephrine—DRD2—hypertension	1.98e-05	0.00954	CrCbGaD
Arbutamine—ADRB2—Signaling by GPCR—CALM1—hypertension	3.05e-06	7.58e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ADRB1—hypertension	3.05e-06	7.57e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—DRD3—hypertension	3.05e-06	7.57e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CYBA—hypertension	3.05e-06	7.57e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FLT1—hypertension	3.05e-06	7.57e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—KDR—hypertension	3.03e-06	7.53e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CALCA—hypertension	3.02e-06	7.49e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ADRA2A—hypertension	3e-06	7.45e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—GHRL—hypertension	2.99e-06	7.41e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PLAT—hypertension	2.99e-06	7.41e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CALCA—hypertension	2.95e-06	7.32e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—BDKRB2—hypertension	2.95e-06	7.31e-05	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—POMC—hypertension	2.94e-06	7.3e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—F2—hypertension	2.93e-06	7.28e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PRKCB—hypertension	2.93e-06	7.28e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—F2—hypertension	2.92e-06	7.24e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—FN1—hypertension	2.92e-06	7.24e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PRKCB—hypertension	2.92e-06	7.24e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ADRBK1—hypertension	2.91e-06	7.23e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CNR1—hypertension	2.89e-06	7.18e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—BDKRB2—hypertension	2.88e-06	7.15e-05	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—POMC—hypertension	2.88e-06	7.14e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PRKCB—hypertension	2.87e-06	7.12e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—F2—hypertension	2.87e-06	7.12e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CALM2—hypertension	2.86e-06	7.1e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—NOTCH1—hypertension	2.86e-06	7.09e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ADRBK1—hypertension	2.85e-06	7.07e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CNR1—hypertension	2.83e-06	7.02e-05	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—AKT2—hypertension	2.83e-06	7.02e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—DRD2—hypertension	2.82e-06	7e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HTR7—hypertension	2.82e-06	7e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CALM2—hypertension	2.8e-06	6.95e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—GCG—hypertension	2.79e-06	6.93e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PTPN1—hypertension	2.79e-06	6.93e-05	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—AKT2—hypertension	2.77e-06	6.87e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HTR7—hypertension	2.76e-06	6.85e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—DRD2—hypertension	2.76e-06	6.85e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—KL—hypertension	2.74e-06	6.8e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NOTCH2—hypertension	2.74e-06	6.8e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—GCG—hypertension	2.73e-06	6.78e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PTPN1—hypertension	2.73e-06	6.78e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NGFR—hypertension	2.69e-06	6.67e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ITGAV—hypertension	2.69e-06	6.67e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—KNG1—hypertension	2.68e-06	6.65e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—KL—hypertension	2.68e-06	6.65e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NOTCH2—hypertension	2.68e-06	6.65e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—POMC—hypertension	2.67e-06	6.63e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AGTR1—hypertension	2.67e-06	6.61e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PRL—hypertension	2.67e-06	6.61e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—POMC—hypertension	2.66e-06	6.6e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—INS—hypertension	2.65e-06	6.56e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NGFR—hypertension	2.63e-06	6.53e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ITGAV—hypertension	2.63e-06	6.53e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—STK11—hypertension	2.63e-06	6.52e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HDAC1—hypertension	2.63e-06	6.52e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—KNG1—hypertension	2.62e-06	6.51e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—CCL2—hypertension	2.62e-06	6.49e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—POMC—hypertension	2.61e-06	6.49e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PRL—hypertension	2.61e-06	6.47e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AGTR1—hypertension	2.61e-06	6.47e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CXCL10—hypertension	2.61e-06	6.46e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CCL2—hypertension	2.6e-06	6.46e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PLG—hypertension	2.6e-06	6.44e-05	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—RHOA—hypertension	2.59e-06	6.43e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—STK11—hypertension	2.57e-06	6.38e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HDAC1—hypertension	2.57e-06	6.38e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—AKT2—hypertension	2.57e-06	6.37e-05	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PIK3R1—hypertension	2.57e-06	6.37e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IGF1—hypertension	2.56e-06	6.35e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—CCL2—hypertension	2.56e-06	6.35e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—AKT2—hypertension	2.56e-06	6.34e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CXCL10—hypertension	2.55e-06	6.32e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—EGFR—hypertension	2.55e-06	6.32e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PLG—hypertension	2.54e-06	6.3e-05	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—RHOA—hypertension	2.54e-06	6.29e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ADRB2—hypertension	2.53e-06	6.27e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—AKT2—hypertension	2.51e-06	6.23e-05	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PIK3R1—hypertension	2.51e-06	6.23e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PRKCE—hypertension	2.5e-06	6.19e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—VAV3—hypertension	2.47e-06	6.12e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PDGFA—hypertension	2.47e-06	6.12e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PRKCE—hypertension	2.44e-06	6.06e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TGFBR2—hypertension	2.43e-06	6.03e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—SERPINE1—hypertension	2.43e-06	6.03e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PDGFA—hypertension	2.41e-06	5.98e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—VAV3—hypertension	2.41e-06	5.98e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—GNB3—hypertension	2.41e-06	5.97e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TGFBR2—hypertension	2.38e-06	5.9e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AVP—hypertension	2.38e-06	5.89e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—GNB3—hypertension	2.36e-06	5.84e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—RHOA—hypertension	2.36e-06	5.84e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—FGF2—hypertension	2.35e-06	5.84e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—GNAS—hypertension	2.35e-06	5.82e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—RHOA—hypertension	2.34e-06	5.82e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PIK3R1—hypertension	2.33e-06	5.78e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AVP—hypertension	2.32e-06	5.77e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—NOS3—hypertension	2.32e-06	5.76e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PIK3R1—hypertension	2.32e-06	5.76e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—RHOA—hypertension	2.3e-06	5.72e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—APOB—hypertension	2.3e-06	5.7e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—GNAS—hypertension	2.29e-06	5.69e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PTK2—hypertension	2.29e-06	5.67e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PIK3R1—hypertension	2.28e-06	5.66e-05	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—CXCL8—hypertension	2.28e-06	5.65e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—EDN1—hypertension	2.26e-06	5.61e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—APOB—hypertension	2.25e-06	5.57e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CCL5—hypertension	2.24e-06	5.56e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PTK2—hypertension	2.24e-06	5.55e-05	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—CXCL8—hypertension	2.23e-06	5.53e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—EDN1—hypertension	2.21e-06	5.48e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CCL5—hypertension	2.19e-06	5.44e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—LPL—hypertension	2.19e-06	5.44e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—RELA—hypertension	2.18e-06	5.42e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—H2AFX—hypertension	2.18e-06	5.4e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PDGFRB—hypertension	2.17e-06	5.39e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—RPS6KB1—hypertension	2.17e-06	5.39e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ADCY5—hypertension	2.15e-06	5.33e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—LPL—hypertension	2.15e-06	5.32e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MTOR—hypertension	2.14e-06	5.31e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PRKCG—hypertension	2.13e-06	5.29e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—H2AFX—hypertension	2.13e-06	5.28e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—RPS6KB1—hypertension	2.13e-06	5.27e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PDGFRB—hypertension	2.13e-06	5.27e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PRKCA—hypertension	2.12e-06	5.25e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ITGB3—hypertension	2.12e-06	5.25e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—YWHAZ—hypertension	2.1e-06	5.21e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ADCY5—hypertension	2.1e-06	5.21e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PRKCG—hypertension	2.09e-06	5.17e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—SPP1—hypertension	2.08e-06	5.15e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NGF—hypertension	2.08e-06	5.15e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ITGB3—hypertension	2.07e-06	5.14e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PRKCA—hypertension	2.07e-06	5.14e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—CXCL8—hypertension	2.07e-06	5.13e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CXCL8—hypertension	2.06e-06	5.11e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—YWHAZ—hypertension	2.05e-06	5.1e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NGF—hypertension	2.03e-06	5.04e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—SPP1—hypertension	2.03e-06	5.04e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—CXCL8—hypertension	2.02e-06	5.02e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CCR5—hypertension	2.02e-06	5.01e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PRKCD—hypertension	2.02e-06	5.01e-05	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—AKT1—hypertension	1.99e-06	4.93e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HTR2A—hypertension	1.98e-06	4.9e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PRKCD—hypertension	1.98e-06	4.9e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CCR5—hypertension	1.98e-06	4.9e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—C3—hypertension	1.97e-06	4.9e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—IL6—hypertension	1.96e-06	4.85e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HTR2A—hypertension	1.93e-06	4.8e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—C3—hypertension	1.93e-06	4.79e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PDGFB—hypertension	1.92e-06	4.77e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FGFR1—hypertension	1.91e-06	4.74e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HIF1A—hypertension	1.88e-06	4.67e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PDGFB—hypertension	1.88e-06	4.66e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AGT—hypertension	1.88e-06	4.65e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FGFR1—hypertension	1.87e-06	4.64e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MMP9—hypertension	1.86e-06	4.62e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CDKN1A—hypertension	1.85e-06	4.6e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PTEN—hypertension	1.85e-06	4.59e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CALM1—hypertension	1.84e-06	4.58e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HIF1A—hypertension	1.84e-06	4.57e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—LEP—hypertension	1.84e-06	4.56e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—APOE—hypertension	1.84e-06	4.56e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AGT—hypertension	1.84e-06	4.55e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CAV1—hypertension	1.82e-06	4.52e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—APOA1—hypertension	1.82e-06	4.51e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MAPK8—hypertension	1.81e-06	4.49e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—AKT1—hypertension	1.81e-06	4.48e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CALM1—hypertension	1.8e-06	4.48e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—KDR—hypertension	1.8e-06	4.47e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—LEP—hypertension	1.8e-06	4.46e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—APOE—hypertension	1.8e-06	4.46e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CAV1—hypertension	1.78e-06	4.42e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—APOA1—hypertension	1.78e-06	4.41e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—EP300—hypertension	1.76e-06	4.38e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—KDR—hypertension	1.76e-06	4.37e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—F2—hypertension	1.73e-06	4.3e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FN1—hypertension	1.73e-06	4.3e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PRKCB—hypertension	1.73e-06	4.3e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—SRC—hypertension	1.72e-06	4.26e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NOTCH1—hypertension	1.7e-06	4.21e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—F2—hypertension	1.7e-06	4.21e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PRKCB—hypertension	1.7e-06	4.21e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FN1—hypertension	1.7e-06	4.21e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—VEGFA—hypertension	1.67e-06	4.15e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NOTCH1—hypertension	1.66e-06	4.12e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—POMC—hypertension	1.58e-06	3.92e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—INS—hypertension	1.57e-06	3.9e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CCL2—hypertension	1.55e-06	3.83e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—POMC—hypertension	1.54e-06	3.83e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MYC—hypertension	1.54e-06	3.81e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—INS—hypertension	1.54e-06	3.81e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—TGFB1—hypertension	1.53e-06	3.81e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IGF1—hypertension	1.52e-06	3.77e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AKT2—hypertension	1.52e-06	3.77e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—EGFR—hypertension	1.51e-06	3.75e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CCL2—hypertension	1.51e-06	3.75e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—EGFR—hypertension	1.5e-06	3.73e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IGF1—hypertension	1.49e-06	3.69e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AKT2—hypertension	1.48e-06	3.68e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—EGFR—hypertension	1.48e-06	3.67e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—SERPINE1—hypertension	1.44e-06	3.58e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—SERPINE1—hypertension	1.41e-06	3.5e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FGF2—hypertension	1.4e-06	3.46e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—RHOA—hypertension	1.39e-06	3.45e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PIK3R1—hypertension	1.38e-06	3.42e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NOS3—hypertension	1.38e-06	3.42e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FGF2—hypertension	1.37e-06	3.39e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—RHOA—hypertension	1.36e-06	3.38e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PIK3R1—hypertension	1.35e-06	3.34e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NOS3—hypertension	1.35e-06	3.34e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—RELA—hypertension	1.3e-06	3.22e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MTOR—hypertension	1.27e-06	3.15e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—RELA—hypertension	1.27e-06	3.15e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—TP53—hypertension	1.26e-06	3.13e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MTOR—hypertension	1.24e-06	3.08e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CXCL8—hypertension	1.22e-06	3.03e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CXCL8—hypertension	1.19e-06	2.96e-05	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—AKT1—hypertension	1.18e-06	2.93e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—IL6—hypertension	1.16e-06	2.88e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IL6—hypertension	1.16e-06	2.87e-05	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—AKT1—hypertension	1.15e-06	2.86e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—IL6—hypertension	1.14e-06	2.82e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MMP9—hypertension	1.1e-06	2.74e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CDKN1A—hypertension	1.1e-06	2.73e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PTEN—hypertension	1.1e-06	2.72e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MMP9—hypertension	1.08e-06	2.68e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CDKN1A—hypertension	1.08e-06	2.67e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MAPK8—hypertension	1.07e-06	2.67e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PTEN—hypertension	1.07e-06	2.67e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—AKT1—hypertension	1.07e-06	2.66e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—AKT1—hypertension	1.07e-06	2.65e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MAPK8—hypertension	1.05e-06	2.61e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—AKT1—hypertension	1.05e-06	2.6e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—EP300—hypertension	1.05e-06	2.6e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—EP300—hypertension	1.02e-06	2.54e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—SRC—hypertension	1.02e-06	2.53e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—SRC—hypertension	9.96e-07	2.47e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—VEGFA—hypertension	9.92e-07	2.46e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—VEGFA—hypertension	9.71e-07	2.41e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MYC—hypertension	9.13e-07	2.26e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TGFB1—hypertension	9.11e-07	2.26e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MYC—hypertension	8.93e-07	2.21e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—EGFR—hypertension	8.93e-07	2.21e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TGFB1—hypertension	8.91e-07	2.21e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—EGFR—hypertension	8.73e-07	2.17e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TP53—hypertension	7.5e-07	1.86e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TP53—hypertension	7.33e-07	1.82e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IL6—hypertension	6.86e-07	1.7e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IL6—hypertension	6.71e-07	1.67e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AKT1—hypertension	6.33e-07	1.57e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AKT1—hypertension	6.19e-07	1.54e-05	CbGpPWpGaD
